ROLE OF FLOW CYTOMETRY IN THE DIAGNOSIS OF HEMATOLOGIC DISEASES

Nguyễn Quang Đẳng 1 , Đào Thị Phương Anh 1 , Nguyễn Thị Mỹ Linh 1 ,
1 Thong Nhat Hospital image/svg+xml
* Corresponding author:

Article Information

Metrics
Downloads: 10 Views: 25
DOI
10.63947/bvtn.v2i6.13
Published
2026-02-27
Issue Vol. 2 No. 6 (2026): Thách thức trong lão khoa 2026: Những giải pháp điều trị và chăm sóc toàn diện
Section
Original Research
Categories
Research

Download Article

PDF (Vietnamese)

How to Cite

1.
Quang Đẳng N, Thị Phương Anh Đào, Thị Mỹ Linh N. ROLE OF FLOW CYTOMETRY IN THE DIAGNOSIS OF HEMATOLOGIC DISEASES. JHA [Internet]. Vietnam; 2026 Feb. 27 [cited 2026 Mar. 15];2(6):88–94. https://tcsuckhoelaohoa.vn/bvtn/article/view/152 doi: 10.63947/bvtn.v2i6.13
Loading citation...
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

This study aimed to describe the characteristics of common hematological disorders through immunophenotypic analysis using flow cytometry (FCM). A retrospective descriptive study was conducted on all patients aged 16 years and older who were analyzed by FCM testing at the Hematology Department, Thong Nhat Hospital from January 2023 to March 2025. Convenience sampling was applied. Data analysis was performed using Microsoft Excel 2021. A total of 104 patients were tested by flow cytometry. The median age at diagnosis was 68 years [55.8–77]. Baseline hematologic findings showed anemia (Hb 9.3 ± 2.6 g/dL) and wide variations in white blood cell (20.1 ± 42.4 K/uL) and platelet counts (197 ± 172.3 K/uL), reflecting the diversity of underlying hematologic conditions. FCM demonstrated high diagnostic value in identifying and classifying various hematologic disorders: distinguishing acute leukemia lineages (myeloid/B-lymphoid/T-lymphoid), detecting monoclonal lymphoid populations in lymphomas, and differentiating benign from malignant plasma cells in multiple myeloma. Correlation with bone marrow morphology was high, especially in diagnostically challenging cases. However, FCM could not fully replace bone marrow examination in assessing cellular morphology and tissue architecture. In conclusion, Flow cytometry is a powerful complementary tool in the diagnosis of hematologic disorders. The combination of FCM and bone marrow studies provides optimal diagnostic accuracy and supports effective patient management.

 

Keywords

flow cytometry hematological disorders

References

  1. Fiona E Craig, Foon Kenneth A %J Blood, The Journal of the American Society of Hematology. Flow cytometric immunophenotyping for hematologic neoplasms. 2008;111(8):3941-3967. DOI: https://doi.org/10.1182/blood-2007-11-120535
  2. K. M. McKinnon. Flow Cytometry: An Overview. Curr Protoc Immunol.2018;120:5 1 1-5 1 11. doi:10.1002/cpim.40 DOI: https://doi.org/10.1002/cpim.40
  3. E. Verigou, Chatzilygeroudi T., Lazaris V., et al. Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era. Front Oncol.2024;14:1447001. doi:10.3389/fonc.2024.1447001 DOI: https://doi.org/10.3389/fonc.2024.1447001
  4. F. Ally, Chen X. Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry. Cancers (Basel).2024;16(22)doi:10.3390/cancers16223855 DOI: https://doi.org/10.3390/cancers16223855
  5. American Society of Hematology. https://www.hematology.org/education/trainees/fellows/case-studies/flow-cytometry-pattern-apl
  6. A. Chan, Scarpa Carniello J. V., Gao Q., et al. Role of Flow Cytometric Immunophenotyping for Classic Hodgkin Lymphoma in Small Biopsy and Cytology Specimens. Arch Pathol Lab Med.2022;146(4):462-468. doi:10.5858/arpa.2020-0795-OA DOI: https://doi.org/10.5858/arpa.2020-0795-OA

License

© 2026 The Author(s). Published by Journal of Health and Aging.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.